Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12608000164392
Ethics application status
Approved
Date submitted
30/03/2008
Date registered
4/04/2008
Date last updated
9/09/2014
Type of registration
Prospectively registered
Titles & IDs
Public title
Cognitive behaviour therapy for co-morbid chronic headache and depression
Query!
Scientific title
Evaluation of Cognitive behaviour therapy for reducing headaches and decreasing depression.
Query!
Secondary ID [1]
285310
0
Nil known
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
HeaD-ON
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Chronic headache
2974
0
Query!
Major depressive disorder
2975
0
Query!
Condition category
Condition code
Neurological
3116
3116
0
0
Query!
Other neurological disorders
Query!
Mental Health
3117
3117
0
0
Query!
Depression
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
The intervention involves 12 50-minute sessions and includes: education about headaches and depression; relaxation training; scheduling pleasant activities; social skills training; training to challenge dysfunctional thoughts and underlying beliefs; problem solving training; identifying and managing headache triggers; training in pain management techniques; lifestyle management; and relapse prevention training.
Query!
Intervention code [1]
2712
0
Behaviour
Query!
Comparator / control treatment
Routine primary care - participants in this group will be case managed by their GPs as they would in the absence of the study, with small variations. No attempt will be made to restrict GPs in terms of prescribed medication but records of prescribed medication will be maintained.
Query!
Control group
Active
Query!
Outcomes
Primary outcome [1]
4005
0
Headache activity - an index determined by headache frequency, severity and duration
Query!
Assessment method [1]
4005
0
Query!
Timepoint [1]
4005
0
Post-treatment and 4-month follow-up
Query!
Primary outcome [2]
4006
0
Depression - level of severity - using Beck Depression Inventory
Query!
Assessment method [2]
4006
0
Query!
Timepoint [2]
4006
0
Post-treatment and 4-month follow-up
Query!
Secondary outcome [1]
6743
0
Anxiety - level of severity - using Beck Anxiety Inventory
Query!
Assessment method [1]
6743
0
Query!
Timepoint [1]
6743
0
Post-treatment and 4-month follow-up
Query!
Secondary outcome [2]
6744
0
Quality of life - using the complementary SF-36 from the Medical Outcomes Study, and the Australian Quality of Life instrument.
Query!
Assessment method [2]
6744
0
Query!
Timepoint [2]
6744
0
Post-treatment and 4-month follow-up
Query!
Eligibility
Key inclusion criteria
Diagnosed as tension-type headache or migraine, minimum of 6 headaches per month, minimum chronicity of 12 months and pattern stable over 6 months, and diagnosed as major depressive disorder.
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
65
Years
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
Major psychiatric disorders other than anxiety disorders, factors interfering with giving informed consent or benefiting from treatment, and medical conditions with over riding treatment requirements.
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Subjects will be recruited through General Practitioners. After individuals have consented to taking part in the study and been assessed as meeting the eligibility criteria for the study, they will be referred to an Associate Investigator for allocation to the treatment conditions. This Associate Investigator will not meet any of the participants or have any information about them, as his role will be restricted to the allocation to treatment conditions and subsequent statistical analysis of data.
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
A computer-generated sequence will be used following the CONSORT guidelines. A stratified randomisation procedure will be used to allocate subjects to the two conditions, with stratification based on diagnosis (migraine versus tension-type headache).
Query!
Masking / blinding
Open (masking not used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Not Applicable
Query!
Type of endpoint/s
Efficacy
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Completed
Query!
Date of first participant enrolment
Anticipated
1/06/2008
Query!
Actual
28/07/2008
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
27/01/2012
Query!
Date of last data collection
Anticipated
Query!
Actual
Query!
Sample size
Target
100
Query!
Accrual to date
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
VIC
Query!
Funding & Sponsors
Funding source category [1]
3238
0
Government body
Query!
Name [1]
3238
0
beyondblue: the national depression initiative
Query!
Address [1]
3238
0
PO Box 6100
50 Burwood Road
Hawthorn West
Victoria 3122
Query!
Country [1]
3238
0
Australia
Query!
Primary sponsor type
University
Query!
Name
Monash University
Query!
Address
Wellington Road
Clayton
Victoria 3800
Query!
Country
Australia
Query!
Secondary sponsor category [1]
2896
0
Hospital
Query!
Name [1]
2896
0
Southern Health
Query!
Address [1]
2896
0
Monash Medical Centre
246 Clayton Road
Clayton, Victoria 3168
Query!
Country [1]
2896
0
Australia
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
5219
0
Southern Health
Query!
Ethics committee address [1]
5219
0
Monash Medical Centre, Research Directorate, Level 4, Main Block, 246 Clayton Road, Clayton, Victoria 3168
Query!
Ethics committee country [1]
5219
0
Australia
Query!
Date submitted for ethics approval [1]
5219
0
22/04/2008
Query!
Approval date [1]
5219
0
21/07/2008
Query!
Ethics approval number [1]
5219
0
08062A
Query!
Summary
Brief summary
Numerous studies have demonstrated comorbidity between migraine and tension-type headache on the one hand, and depression on the other. It is not clear whether this reflects a causal relationship between headaches and depression or common predispositional factors. Presence of depression is a negative prognostic indicator for behavioral treatment of headaches. Despite the recognised comorbidity, there is limited research literature evaluating interventions designed for comorbid headaches and depression. Sixty six participants (49 female, 17 male) suffering from migraine and/or tension-type headache and major depressive disorder were randomly allocated to a Cognitive Behavior Therapy program, or a control group (Routine Primary Care). The treatment program involved 12 weekly 50-minute sessions administered by clinical psychologists. Participants in the treatment and control groups significantly differed from baseline to post-treatment on measures of headaches, depression, anxiety, and quality of life. Improvements achieved with treatment were maintained at four month follow-up. Changes in headaches and depression were not significantly correlated suggesting that the relationship between them may not be causal. Comorbid anxiety disorders were not a predictor of response to treatment, and the only significant predictor was gender (men improved more than women). The new integrated treatment program appears promising and worthy of further investigation.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
28475
0
Prof Paul R Martin
Query!
Address
28475
0
School of Applied Psychology, Griffith University, Mt Gravatt Campus, 176 Messines Ridge Road, Mt Gravatt, Queensland 4122.
Query!
Country
28475
0
Australia
Query!
Phone
28475
0
+61 07 3735 3322
Query!
Fax
28475
0
+61 07 3735 3388
Query!
Email
28475
0
[email protected]
Query!
Contact person for public queries
Name
11632
0
Paul R Martin
Query!
Address
11632
0
School of Applied Psychology, Griffith University, Mt Gravatt Campus, 176 Messines Ridge Road, Mt Gravatt, Queensland 4122.
Query!
Country
11632
0
Australia
Query!
Phone
11632
0
+61 07 3735 3322
Query!
Fax
11632
0
+61 07 3735 3388
Query!
Email
11632
0
[email protected]
Query!
Contact person for scientific queries
Name
2560
0
Paul Martin
Query!
Address
2560
0
School of Applied Psychology, Griffith University, Mt Gravatt Campus, 176 Messines Ridge Road, Mt Gravatt, Queensland 4122.
Query!
Country
2560
0
Australia
Query!
Phone
2560
0
+61 07 3735 3322
Query!
Fax
2560
0
+61 07 3735 3388
Query!
Email
2560
0
[email protected]
Query!
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
Source
Title
Year of Publication
DOI
Embase
Cognitive behavior therapy for comorbid migraine and/or tension-type headache and major depressive disorder: An exploratory randomized controlled trial.
2015
https://dx.doi.org/10.1016/j.brat.2015.07.005
N.B. These documents automatically identified may not have been verified by the study sponsor.
Download to PDF